Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Enzon Pharma Inc (ENZN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 11,807
  • Shares Outstanding, K 44,220
  • Annual Sales, $ 8,380 K
  • Annual Income, $ -1,130 K
  • 36-Month Beta 1.21
  • Price/Sales 1.26
  • Price/Cash Flow 0.00
  • Price/Book 0.69
  • Price/Earnings ttm 11.90
  • Earnings Per Share ttm 0.02
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/09/17
  • Annual Dividend & Yield 0.15 (63.03%)
  • Most Recent Dividend 0.30 on 12/13/16
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2239 +29.52%
on 09/29/17
0.3900 -25.64%
on 09/25/17
-0.0860 (-22.87%)
since 09/18/17
3-Month
0.2239 +29.52%
on 09/29/17
0.4000 -27.50%
on 08/29/17
-0.0710 (-19.67%)
since 07/18/17
52-Week
0.2200 +31.82%
on 05/09/17
0.4990 -41.88%
on 11/30/16
-0.0711 (-19.69%)
since 10/18/16

Most Recent Stories

More News
Enzon Pharmaceuticals Partnering Deals and Alliances 2010 to 2017

SummaryThis report provides all the information you require to better understand Enzon Pharmaceuticals and its partnering interests and activities since 2010.

ENZN : 0.2900 (+8.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More

Support & Resistance

2nd Resistance Point 0.3217
1st Resistance Point 0.2943
Last Price 0.2900
1st Support Level 0.2393
2nd Support Level 0.2117

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart